FREE EXPRESS SHIPPING ON ORDERS OVER $200
CJC-1295 + GHRP-6 2x Combo
$520.00
$465.00
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), comprising a modified 29-amino acid sequence with Drug Affinity Complex chemistry. The molecule includes amino acid substitutions and a lysine-linked maleimidopropionyl group used in albumin-binding research models. Molecular weight: approximately 3,647.3 g/mol. GHRP-6 is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. It belongs to the growth hormone-releasing peptide family and contains D-amino acid residues. Molecular formula: C46H56N12O6. Molecular weight: approximately 873.0 g/mol.
Supplied as separate lyophilised powders with >=99% purity verified by third-party HPLC analysis. A Certificate of Analysis is available for each batch. Each combo set contains 5mg CJC-1295, 5mg GHRP-6; this product contains 2 combo sets.
Store at -20°C for long-term stability. Once reconstituted with WFI (Water for Injection), store at 4°C and use within 30 days. Protect from direct light and heat.
This product is intended for laboratory and in-vitro research purposes only and is not for human or animal consumption.
Quantity
KEY BENEFITS
CJC-1295:
- Increases natural growth hormone production
- Promotes muscle development and recovery
- Supports skin regeneration and anti-aging research
- Enhances overall vitality
GHRP-6:
- Stimulates growth hormone release
- Supports muscle development and recovery
- Promotes appetite stimulation for enhanced energy intake
- May assist in fat loss when used in proper research protocols
DOSAGE AND CYCLE DURATION
CJC-1295:
- Dosing usually falls between 200 and 300 mcg daily, administered by subcutaneous injection.
- Cycles typically range from 8 to 12 weeks, followed by an evaluation period.
GHRP-6:
- Dosing ranges from 100 to 200 mcg per injection, administered by subcutaneous injection daily.
- Cycles usually extend for 8 to 12 weeks with designated rest periods between cycles.
